Recent News

• 08.11.2026 - The Future of Oncology Trials in the UK: Navigating the UK CTR 2026 Regulatory Reboot
• 08.10.2026 - Fortrea Innovation & Technology Summit – EU
• 08.10.2026 - SCRS Global Site Solutions Summit 2026
• 08.05.2026 - The primary constraint on AI in clinical trials is organizational uncertainty, not regulatory objections
• 08.04.2026 - The Changing Landscape for Human Absorption, Metabolism, and Excretion: Practical Experiences From a Data Analysis of 500 Studies
• 08.04.2026 - Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer
• 08.04.2026 - Human ADME (hAME) Studies
• 07.30.2026 - Madison Clinical Research Unit: Sponsor overview
• 07.29.2026 - Outsourcing in Clinical Trials Southern California 2026
• 07.28.2026 - Coordinating complexity: Delivering global diagnostic imaging studies across modalities and patient populations

Recent Filings

• 08.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2026 - 144 Report of proposed sale of securities
• 08.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2026 - 144 Report of proposed sale of securities
• 08.03.2026 - 144 Report of proposed sale of securities
• 07.29.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.29.2026 - 8-K Current report
• 07.29.2026 - EX-99.1 EX-99.1